Triamcinolone acetonide
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 2 |
Source: | Medsafe |
---|
Side effects: | 16 |
Source: | FDA |
---|
Side effects: | 10 |
Source: | FDA |
---|
Side effects: | 19 |
Source: | Health Canada |
---|
Side effects: | 29 |
Source: | Health Canada |
---|
Side effects: | 31 |
Source: | FDA Structured Product Label |
---|
Side effects: | 31 |
Source: | FDA |
---|
Side effects: | 33 |
Source: | FDA |
---|
Side effects: | 33 |
Source: | FDA |
---|
Side effects: | 34 |
Source: | FDA |
---|
Side effects: | 7 |
Source: | FDA Structured Product Label |
---|
Side effects: | 11 |
Source: | FDA Structured Product Label |
---|
Side effects: | 11 |
Source: | FDA Structured Product Label |
---|
Side effects: | 11 |
Source: | FDA Structured Product Label |
---|
Side effects: | 26 |
Source: | Medsafe |
---|
Side effects: | 100 |
Source: | Medsafe |
---|
Side effects: | 103 |
Source: | Medsafe |
---|
Side effects: | 94 |
Source: | FDA Structured Product Label |
---|
Side effects: | 94 |
Source: | FDA |
---|
Side effects: | 94 |
Source: | FDA Structured Product Label |
---|
Side effects: | 94 |
Source: | FDA Structured Product Label |
---|
Side effects: | 98 |
Source: | FDA Structured Product Label |
---|
Side effects: | 100 |
Source: | FDA Structured Product Label |
---|
Side effects: | 108 |
Source: | FDA |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|